Swallow preservation exercises during chemoradiation therapy maintains swallow function

Otolaryngol Head Neck Surg. 2013 Dec;149(6):878-84. doi: 10.1177/0194599813502310. Epub 2013 Aug 27.

Abstract

Objective: To evaluate a swallow preservation protocol (SPP) in which patients received swallow therapy before, during, and after radiation treatment and its efficacy in maintaining swallowing function in head and neck cancer patients.

Design: Case series with chart review.

Setting: Tertiary care academic medical center.

Subjects and methods: Eighty-five patients who received radiation (RT) or chemoradiation (CRT) participated in the SPP from 2007 to 2012. Subjects were divided into 2 groups: compliant and noncompliant with SPP. At each SPP visit, the diet of each patient was recorded as regular (chewable), puree, liquid, or gastrostomy tube (G-tube) dependent, along with their compliance with the swallow exercises. Patients were stratified by age, gender, tumor stage, type of treatment, radiation dose, diet change, dysguesia, odynophagia, pain, and stenosis. Statistical analysis was performed comparing the 2 compliance groups in regards to swallowing-related outcomes at 1 month after completion of therapy.

Results: Fifty-seven patients were compliant and 28 were noncompliant with SPP during treatment. The compliant group had a higher percentage of patients tolerating a regular diet (54.4% vs 21.4%, P = .008), a lower G-tube dependence (22.8% vs 53.6%, P = .008), and a higher rate of maintaining or improving their diet (54.4% vs 25.0%, P = .025) compared to noncompliant patients.

Conclusion: A swallow preservation protocol appears to help maintain or improve swallow function in head and neck cancer patients undergoing RT or CRT. Patients who are able to comply with swallow exercises are less likely to worsen their diet, receive a G-tube, or develop stenosis.

Keywords: radiation and swallow; swallow preservation; swallow therapy.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chemoradiotherapy, Adjuvant* / adverse effects
  • Deglutition / drug effects*
  • Deglutition / radiation effects*
  • Deglutition Disorders / epidemiology
  • Deglutition Disorders / physiopathology
  • Deglutition Disorders / therapy*
  • Exercise Therapy*
  • Female
  • Head and Neck Neoplasms / therapy*
  • Hospitals, University
  • Humans
  • Incidence
  • Los Angeles / epidemiology
  • Male
  • Middle Aged
  • Patient Compliance / statistics & numerical data
  • Retrospective Studies
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome